AbbVie Executive and Leadership Team

Pinar Ceylan, the Director, Finance & Chief Financial Officer at AbbVie, manages the fiscal health and capital allocation strategies for the organization. Ceylan oversees financial planning, reporting, and risk management to ensure sustainable growth across international markets. By directing budgetary discipline, the Director, Finance & Chief Financial Officer supports the massive R&D investments required for discovering innovative medicines. Pinar Ceylan collaborates with the executive team to optimize the cost structure of clinical operations and commercial activities. This leadership role involves maintaining transparency with stakeholders while driving long-term financial stability. Through rigorous financial oversight, Ceylan ensures that resources remain available for addressing unmet medical needs in neuroscience and eye care. The Director, Finance & Chief Financial Officer monitors global economic trends to mitigate risks, securing the financial foundation necessary for the company to continue delivering high-impact health solutions to patients worldwide.

Hasan Kurt, the Chief Financial Officer, Integration Lead Allergan Aesthetics at AbbVie, directs the financial integration of the medical aesthetics portfolio. Kurt oversees the consolidation of financial systems and operational processes to maximize the value of the aesthetics business unit. By managing the fiscal transition, the Chief Financial Officer, Integration Lead Allergan Aesthetics ensures that the aesthetics division remains a high-growth contributor to the company's overall revenue. Hasan Kurt aligns the financial performance of this specialty area with the broader corporate strategy. This leadership role involves evaluating investment opportunities and operational synergies to enhance market position. Through strategic financial oversight, Kurt supports the continued innovation in medical aesthetics, ensuring that the division meets the needs of patients seeking specialty health solutions. The Chief Financial Officer, Integration Lead Allergan Aesthetics drives profitability and operational efficiency, securing the long-term success of the aesthetics portfolio within the global organization.

Scott Reents, the Executive VP & Chief Financial Officer at AbbVie, leads the global financial strategy and capital management for the entire organization. Reents oversees the company's financial reporting, treasury operations, and investor relations to ensure transparency and fiscal strength. By directing the allocation of capital, the Executive VP & Chief Financial Officer supports the massive R&D investments required to discover and develop innovative medicines. Scott Reents collaborates with the Board and executive leadership to define the company's long-term financial goals and growth trajectory. This leadership role involves managing the financial risks associated with global pharmaceutical operations. Through strategic financial planning, Reents ensures that the company maintains the resources necessary to address complex medical challenges. The Executive VP & Chief Financial Officer drives the financial performance of the organization, ensuring that every investment supports the mission of delivering life-altering health solutions to patients worldwide.

Portia Chen, the Chief of Staff at AbbVie, coordinates executive workflows to ensure alignment with the biopharmaceutical mission. Chen manages cross-functional communication channels, facilitating rapid decision-making across the global organization. By streamlining internal processes, the Chief of Staff enables leadership to focus on the discovery and development of innovative medicines. Portia Chen maintains oversight of high-priority initiatives, ensuring that resources remain directed toward addressing complex medical challenges. This role involves constant interaction with senior management to refine operational efficiency and support the delivery of health solutions. Through meticulous planning and execution, the Chief of Staff drives the organizational agility required to maintain a competitive edge in the pharmaceutical industry. Chen fosters a culture of accountability, ensuring that every strategic objective aligns with the broader goal of improving patient quality of life.

Mark Schacher, the Director, Data and Statistical Science and Chief of Staff at AbbVie, architects the analytical frameworks necessary for rigorous clinical research. Schacher oversees the integration of complex datasets to validate the efficacy of new therapeutic candidates. By leveraging advanced statistical modeling, the Director, Data and Statistical Science and Chief of Staff ensures that clinical trials meet the highest standards of scientific integrity. Mark Schacher bridges the gap between raw data insights and executive strategy, providing the evidence base for critical investment decisions in immunology and oncology. This leadership role involves managing large-scale data infrastructure to support global research operations. Through the application of predictive analytics, Schacher accelerates the development cycle of life-altering medicines. The Director, Data and Statistical Science and Chief of Staff maintains a focus on data-driven outcomes, ensuring that every research initiative contributes directly to the company's portfolio of specialty health solutions.

Sarah Kopecky-Bromberg, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff at AbbVie, designs the operational roadmaps for specialty therapeutic development. Kopecky-Bromberg aligns development timelines with commercial objectives to ensure the efficient delivery of new treatments. By managing the intersection of clinical operations and strategic planning, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff optimizes the path from discovery to market. Sarah Kopecky-Bromberg coordinates with cross-functional teams to resolve bottlenecks in the development pipeline. This leadership role involves translating complex medical requirements into actionable operational plans that support the company's focus on serious, life-altering diseases. Through proactive resource management, Kopecky-Bromberg ensures that development efforts remain synchronized with global market demands. The Strategic Planning Director, Development & Operations, Specialty Chief of Staff drives operational excellence, ensuring that every phase of the development process contributes to the overall mission of improving patient outcomes.

Nancy Radcliffe, the Senior Coordinator - Chief Revenue Officer and Trade Accounts at AbbVie, manages the operational interface between revenue generation and trade account management. Radcliffe oversees the coordination of commercial activities to ensure seamless product distribution and revenue recognition. By streamlining communication between the Chief Revenue Officer and key trade partners, the Senior Coordinator - Chief Revenue Officer and Trade Accounts facilitates the efficient delivery of medicines to patients. Nancy Radcliffe monitors account performance and market access metrics to support the company's commercial strategy. This leadership role involves managing complex trade relationships to ensure that health solutions reach the intended medical markets. Through meticulous coordination, Radcliffe supports the revenue growth necessary to fund ongoing research and development. The Senior Coordinator - Chief Revenue Officer and Trade Accounts maintains a focus on operational efficiency, ensuring that commercial operations remain aligned with the broader goal of addressing significant unmet medical needs.

Martin Hayes, the Global Neuroscience & Ophthalmology Research Chief of Staff at AbbVie, coordinates the research activities within the neuroscience and eye care therapeutic areas. Hayes manages the operational flow of research projects, ensuring that scientific teams have the resources to address complex medical challenges. By facilitating collaboration between researchers and clinical leads, the Global Neuroscience & Ophthalmology Research Chief of Staff accelerates the discovery of new treatments. Martin Hayes oversees the alignment of research milestones with the company's long-term development goals. This leadership role involves managing the research portfolio to ensure a steady pipeline of innovative medicines. Through effective coordination, Hayes supports the scientific efforts aimed at managing chronic and serious diseases. The Global Neuroscience & Ophthalmology Research Chief of Staff drives research productivity, ensuring that every scientific endeavor contributes to the company's mission of improving patient quality of life through advanced neuroscience and ophthalmology solutions.

Carla Stalfa, the Chief Marketing Officer & Trial Management Analyst at AbbVie, directs the commercial messaging and trial management analytics for the company's therapeutic portfolio. Stalfa oversees the development of marketing strategies that communicate the value of innovative medicines to healthcare providers and patients. By integrating trial management data into marketing campaigns, the Chief Marketing Officer & Trial Management Analyst ensures that promotional efforts remain grounded in clinical evidence. Carla Stalfa manages the brand positioning of specialty health solutions to maximize market impact. This leadership role involves analyzing trial outcomes to refine commercial messaging and improve patient access. Through data-driven marketing, Stalfa supports the growth of the company's core therapeutic areas. The Chief Marketing Officer & Trial Management Analyst drives brand awareness and market adoption, ensuring that the company's life-altering therapies reach the patients who need them most while maintaining a focus on clinical integrity.

Brian Szopinski, the Director, Clinical Operations & Chief of Staff at AbbVie, manages the execution of global clinical trials. Szopinski oversees the operational logistics, site management, and regulatory compliance required to conduct high-quality research. By directing the clinical operations team, the Director, Clinical Operations & Chief of Staff ensures that trials proceed on schedule and within budget. Brian Szopinski coordinates with the Chief of Staff to align clinical activities with the company's broader strategic objectives. This leadership role involves managing the complexities of international clinical research to support the development of new medicines. Through rigorous operational oversight, Szopinski ensures that clinical data meets the standards necessary for regulatory approval. The Director, Clinical Operations & Chief of Staff drives efficiency in the trial process, ensuring that the company can continue to deliver innovative health solutions that address some of the world's most complex medical challenges.